Acurx Pharmaceuticals, Inc. (ACXP)
| Previous Close | 1.9800 |
| Open | 1.9925 |
| Bid | 1.9200 x 100 |
| Ask | 2.0700 x 100 |
| Day's Range | 1.9400 - 2.0400 |
| 52 Week Range | 1.1700 - 8.8200 |
| Volume | |
| Avg. Volume | 105,588 |
| Market Cap | 32.144M |
| Beta (5Y Monthly) | -1.90 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.1500 |
| Earnings Date | May 15, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 12.09 |
PR NewswireAcurx Pharmaceuticals, Inc. to Discuss First Quarter 2024 Financial Results on May 15, 2024 Conference Call and Provide Business Update
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today that the Company will release its first quarter 2024 financial results on Wednesday, May 15, 2024, at 8:00 am ET before the U.S. financial markets open.
- Newsfile
Acurx Pharmaceuticals, Inc. Announces Participation in the LD Micro Invitational XIV
Staten Island, New York--(Newsfile Corp. - March 21, 2024) - Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) announced today that it will be presenting at The 14th Annual LD Micro Invitational at the Sofitel New York on April 8th-9th, 2024. The event is expected to feature 80 companies presenting in half-hour increments, as well as private 1:1 meetings. Acurx Pharmaceuticals, Inc. is scheduled to present on April 8th at 2:30 pm ET. David ...
Insider MonkeyAcurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q4 2023 Earnings Call Transcript
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q4 2023 Earnings Call Transcript March 18, 2024 Acurx Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings and welcome to the Acurx Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Earnings Results and […]
